Abstract

The therapeutic application of human induced pluripotent stem cells (hiPSCs) for cartilage regeneration is largely hindered by the low yield of chondrocytes accompanied by unpredictable and heterogeneous off-target differentiation of cells during chondrogenesis. Here, we combine bulk RNA sequencing, single cell RNA sequencing, and bioinformatic analyses, including weighted gene co-expression analysis (WGCNA), to investigate the gene regulatory networks regulating hiPSC differentiation under chondrogenic conditions. We identify specific WNTs and MITF as hub genes governing the generation of off-target differentiation into neural cells and melanocytes during hiPSC chondrogenesis. With heterocellular signaling models, we further show that WNT signaling produced by off-target cells is responsible for inducing chondrocyte hypertrophy. By targeting WNTs and MITF, we eliminate these cell lineages, significantly enhancing the yield and homogeneity of hiPSC-derived chondrocytes. Collectively, our findings identify the trajectories and molecular mechanisms governing cell fate decision in hiPSC chondrogenesis, as well as dynamic transcriptome profiles orchestrating chondrocyte proliferation and differentiation. Application of human induced pluripotent stem cells (hiPSCs) for tissue regeneration is hindered by off-target cell differentiation. Here, the authors use bulk and single cell RNA-sequencing to identify WNT and MITF as off-target hubs during chondrogenic differentiation; inhibiting these pathways enhanced homogeneity and yield.

Highlights

  • The therapeutic application of human induced pluripotent stem cells for cartilage regeneration is largely hindered by the low yield of chondrocytes accompanied by unpredictable and heterogeneous off-target differentiation of cells during chondrogenesis

  • We demonstrate that the homogeneity of human induced pluripotent stem cells (hiPSCs) chondrogenesis can be significantly improved by inhibiting the molecular targets WNTs and melanocyte-inducing TF (MITF)

  • The therapeutic applications of hiPSCs for cartilage regeneration or disease modeling have been limited by the low-yield of bona fide chondrocytes, accompanied by off-target populations during chondrogenic differentiation

Read more

Summary

Introduction

The therapeutic application of human induced pluripotent stem cells (hiPSCs) for cartilage regeneration is largely hindered by the low yield of chondrocytes accompanied by unpredictable and heterogeneous off-target differentiation of cells during chondrogenesis. We identify specific WNTs and MITF as hub genes governing the generation of off-target differentiation into neural cells and melanocytes during hiPSC chondrogenesis. Studies reported that chondrocytes can be generated from hiPSCs via embryoid body formation followed by monolayer expansion of mesodermal cells and three-dimensional cell pellet culture in chondrogenic induction medium[2,3]. Despite some success, this approach was proven difficult to reproduce across different iPSC lines, potentially due to variability in lots of fetal bovine serum (FBS) generally used for cell expansion. Neuronal differentiation 4 (NEUROD4), a gene encoding a transcriptional activator essential for neuronal differentiation, had increased expression in d14 pellets[12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call